BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25018058)

  • 1. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.
    Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma.
    Hsueh YM; Lin YC; Chen WJ; Huang CY; Shiue HS; Pu YS; Chen CH; Su CT
    Toxicol Appl Pharmacol; 2017 Oct; 332():1-7. PubMed ID: 28733204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population.
    Kumar A; Pant MC; Singh HS; Khandelwal S
    Mutat Res; 2012 Jan; 729(1-2):24-34. PubMed ID: 21945240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
    Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
    Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population.
    Radwan WM; Elbarbary HS; Alsheikh NM
    Ren Fail; 2015 Feb; 37(1):122-8. PubMed ID: 25310768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XRCC1 Polymorphisms and Urinary 8-Hydroxydeoxyguanine Levels Are Associated with Urothelial Carcinoma.
    Chiang CI; Huang YL; Huang CY; Shiue HS; Chen WJ; Pu YS; Lin YC; Hsueh YM
    PLoS One; 2015; 10(5):e0124066. PubMed ID: 25938407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and haplotype associations of XPD Lys751Gln, XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms with nasopharyngeal carcinoma in the Malaysian population.
    Visuvanathan S; Chong PP; Yap YY; Lim CC; Tan MK; Lye MS
    Asian Pac J Cancer Prev; 2014; 15(6):2747-51. PubMed ID: 24761895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.
    Trabulus S; Guven GS; Altiparmak MR; Batar B; Tun O; Yalin AS; Tunckale A; Guven M
    Mol Biol Rep; 2012 Jun; 39(6):6995-7001. PubMed ID: 22302399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan.
    Yeh CC; Sung FC; Tang R; Chang-Chieh CR; Hsieh LL
    BMC Cancer; 2005 Jan; 5():12. PubMed ID: 15679883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
    Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
    Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
    Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk.
    Guo LY; Jin XP; Niu W; Li XF; Liu BH; Wang YL
    Asian Pac J Cancer Prev; 2012; 13(9):4423-6. PubMed ID: 23167354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.
    Gan Y; Li XR; Chen DJ; Wu JH
    Asian Pac J Cancer Prev; 2012; 13(11):5721-4. PubMed ID: 23317245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of XRCC1 polymorphisms with arsenic methylation.
    Fujihara J; Yasuda T; Iwata H; Tanabe S; Takeshita H
    Arch Toxicol; 2016 Apr; 90(4):1009-12. PubMed ID: 25731970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
    BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
    De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
    Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia.
    Seedhouse C; Bainton R; Lewis M; Harding A; Russell N; Das-Gupta E
    Blood; 2002 Nov; 100(10):3761-6. PubMed ID: 12393447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk.
    El-Zein R; Monroy CM; Etzel CJ; Cortes AC; Xing Y; Collier AL; Strom SS
    Cancer; 2009 Apr; 115(8):1651-9. PubMed ID: 19280628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency.
    Guven M; Guven GS; Oz E; Ozaydin A; Batar B; Ulutin T; Hacihanefioglu S; Domanic N
    Heart Vessels; 2007 Nov; 22(6):355-60. PubMed ID: 18043991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.
    Sreeja L; Syamala VS; Syamala V; Hariharan S; Raveendran PB; Vijayalekshmi RV; Madhavan J; Ankathil R
    J Cancer Res Clin Oncol; 2008 Jun; 134(6):645-52. PubMed ID: 17952468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.